Skip to main content
Premium Trial:

Request an Annual Quote

Signal Extends Gene Array Testing Services Agreements with UAMS

NEW YORK (GenomeWeb) – Signal Genetics said in a regulatory document on Wednesday that it has reached agreements to exclusively provide gene array clinical genetic testing services to the University of Arkansas for Medical Sciences.

The New York City-based firm signed a reference laboratory services agreement with the board of trustees of the University of Arkansas on behalf of UAMS, Signal said in a document filed with the US Securities and Exchange Commission. It also reached a reference laboratory services agreement for research specimens to be the exclusive provider of gene array clinical genetic testing services for research purposes to UAMS.

Both agreements were entered into on Sept. 19 and remain in effect until Sept. 19, 2017. They can be renewed after the end of the initial term by Signal and UAMS for additional 12-month terms. Financial and other terms of the agreements were not disclosed.

The deals renew and extend Signal's current reference laboratory services agreement and reference laboratory services agreement for research specimens with UAMS, dated March 21, 2011, Signal said.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.